With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.182618-86-6,1-Boc-4-(4-Nitrophenyl)piperazine,as a common compound, the synthetic route is as follows.
To a stirred solution of 61 tert-butyl 4-(4-nitrophenyl)piperazine-1-carboxylate (6.50 g, 21.17 mmol, 1.0 eq) in 100 mL of 6 ethanol: 7 water (1:1) mixture were added 67 NH4Cl (11.40 g, 211 mmol, 10 eq) and Fe(0) (4.70 g, 84.68 mmol, 4.0 eq). Reaction mixture was heated at 80 C. for 4 h. Progress of reaction was monitored by LCMS. Upon the consumption of starting material, solvent was removed under reduced pressure. Aqueous layer was basified with saturated solution of 68 sodium carbonate and extracted with ethyl acetate (200 mL×2). Combined organic layer was washed with 50 mL of brine solution, dried over anhydrous Na2SO4 and concentrated under reduced pressure to obtain 4.0 g (68%) of 69 tert-butyl 4-(4-aminophenyl)piperazine-1-carboxylate.LCMS: 278 [M+1]+
182618-86-6, As the paragraph descriping shows that 182618-86-6 is playing an increasingly important role.
Reference:
Patent; giraFpharma LLC; Chakravarty, Sarvajit; PHAM, Son Minh; Kankanala, Jayakanth; AGARWAL, Anil Kumar; PUJALA, Brahmam; SONI, Sanjeev; ARYA, Satish K.; PALVE, Deepak; KUMAR, Varun; (360 pag.)US2019/106436; (2019); A1;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics